Frontiers | An Immune-Clinical Prognostic Index (ICPI) for Patients With De Novo Follicular Lymphoma Treated With R-CHOP/CHOP Chemotherapy
Follicular Lymphoma International Prognostic Index (FLIPI) and FLIPI-2 - thehematologist.org
Risk Stratification in Follicular Lymphoma
A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy - ScienceDirect
Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression‐free survival and early treatment failure after frontline immunochemotherapy - Mir - 2020 -
Frontiers | An Immune-Clinical Prognostic Index (ICPI) for Patients With De Novo Follicular Lymphoma Treated With R-CHOP/CHOP Chemotherapy
Treatment and Risk-Stratification for High-Risk Follicular Lymphoma - Hematology Advisor
Table 1 from Guidelines for the diagnosis and treatment of follicular lymphoma in China | Semantic Scholar
Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project | Journal of Clinical Oncology
Prognosis and Treatment of Follicular Lymphoma
A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy - ScienceDirect
Outcome and risk of lymphoma progression according a risk groups as... | Download Scientific Diagram
Follicular Lymphoma International Prognostic Index (FLIPI). Online calculator | ClinCaseQuest
A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy | Haematologica
FLIPI and PRIMA-PI risk factors | Download Scientific Diagram
Follicular lymphoma international prognostic Index (FLIPI 1 and FLIPI 2) | Download Table
The clinical applicability of current prognostic models in follicular lymphoma: A systematic review - ScienceDirect
Diagnostics | Free Full-Text | Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy
FLIPI2 | Mike's Chemotherapy for Follicular Cancer Experience
Diagnostics | Free Full-Text | Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy
PFS and OS based on FLIPI and FLIPI2 | Download Table
Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CT | Leukemia
Follicular Lymphoma: Practice Essentials, Etiology and Pathophysiology, Epidemiology
Impact of treatment in long-term survival patients with follicular lymphoma: A Spanish Lymphoma Oncology Group registry | PLOS ONE
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry - The Lancet
Follicular lymphoma international prognostic Index (FLIPI 1 and FLIPI 2) | Download Table
M7‐FLIPI is not prognostic in follicular lymphoma patients with first‐line rituximab chemo‐free therapy - Lockmer - 2020 - British Journal of Haematology - Wiley Online Library
